Samantha Moodie

Sam is experienced in the drafting and prosecution of patent applications before the European Patent Office (EPO) and has extensive experience in the coordination and strategic management of complex worldwide patent portfolios. She also has experience in handing offensive and defensive opposition and appeal proceedings before the EPO, as well as providing freedom to operate and validity opinions. Sam works in the fields of molecular biology and biotechnology, with a particular focus on antibody-based therapeutics, including antibody-toxin fusion proteins; nucleic acid-based diagnostics; and stem cell and regenerative technologies.

Prior to joining the patent profession, Sam worked as a research scientist in the pharmaceutical industry developing therapeutic antibodies for use in the treatment of cancer and immune system disorders.

Sam graduated from Imperial College London with a first class honours degree in biochemistry and a PhD in molecular virology. Her PhD focused on the identification of host factors involved in the Hepatitis C virus replication cycle through the use of microarray expression profiling and siRNA silencing techniques. Sam’s PhD research was the subject of several international presentations and was published in the Journal of Virology.

Sam holds a certificate in Intellectual Property from the University of London where she gained a distinction, and was awarded the GlaxoSmithKline (GSK) prize for excellence in patents. She also holds a certificate in Intellectual Property Litigation.

Sam is a member of the European Patent Institute (EPI) and a member of the Chartered Institute of Patent Attorneys (CIPA).